From the 1 Department of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA.
Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
QJM. 2016 Jul;109(7):453-459. doi: 10.1093/qjmed/hcw048. Epub 2016 Mar 24.
Reports of mortality due to magnesium dysregulation in the critical care setting are controversial. We performed a systematic review and meta-analysis to evaluate the association between hypomagnesemia and mortality in patients admitted to the intensive care unit.
Eligible studies assessing the association between hypomagnesemia or hypermagnesemia and mortality in the critical care setting were comprehensively searched in MEDLINE and EMBASE from their inception to September 2015. Inclusion criteria were published observational studies in adults who were admitted to the intensive or critical care setting with initial serum magnesium measurement. We used the definition of abnormal magnesium level defined by each study. Primary outcome was all-cause mortality. We performed meta-analysis using random-effects model and calculated pooled effect estimate of outcome comparing between hypomagnesemia and normal magnesium category.
From 30 full-text articles, 6 studies involving 1550 participants were included in the meta-analysis. There was a statistically significant higher risk of mortality in critically ill patients who had hypomagnesemia with RR of 1.90 (95% CI: 1.48-2.44, P < 0.001, I(2 )=( )63.5%). Risk for needing mechanical ventilation was also higher in the hypomagnesemia group with RR of 1.65 (95% CI: 1.12-2.43, P = 0.01, I(2 )=( )84%). Length of ICU stay was also higher in the hypomagnesemia group with mean difference of 4.1 days (95% CI: 1.16-7.04, P = 0.01).
The findings of this meta-analysis indicate hypomagnesemia is associated with higher mortality, the need of mechanical ventilation and also the length of ICU stay in patients admitted to ICU.
在重症监护环境中,由于镁调节失常导致死亡的报告存在争议。我们进行了一项系统评价和荟萃分析,以评估重症监护病房中低镁血症与死亡率之间的关系。
全面检索 MEDLINE 和 EMBASE 数据库,从建库至 2015 年 9 月,以评估重症监护环境中低镁血症或高镁血症与死亡率之间的关系。纳入标准为:纳入成年人的观察性研究,这些成年人被收入重症监护或重症监护病房,且最初有血清镁测量值。我们使用每个研究定义的异常镁水平的定义。主要结局为全因死亡率。使用随机效应模型进行荟萃分析,并计算比较低镁血症与正常镁类别之间的结局的汇总效应估计值。
从 30 篇全文文章中,有 6 项研究共纳入 1550 名参与者进行荟萃分析。患有低镁血症的危重病患者死亡风险显著更高,RR 为 1.90(95%CI:1.48-2.44,P<0.001,I(2)=63.5%)。低镁血症组需要机械通气的风险也更高,RR 为 1.65(95%CI:1.12-2.43,P=0.01,I(2)=84%)。低镁血症组 ICU 住院时间也更长,平均差异为 4.1 天(95%CI:1.16-7.04,P=0.01)。
本荟萃分析的结果表明,低镁血症与死亡率升高、机械通气需求以及 ICU 住院时间延长有关。